1. FRI0393 Prevalence of myositis-specific antibodies in idiopathic inflammatory myopathy compared to disease and healthy controls. (15th June 2017) Authors: Vulsteke, J-B; Bossuyt, X; Dillaerts, D; Poesen, K; Claeys, K; Lenaerts, J; Westhovens, R; Blockmans, D; Haes, P De; Langhe, E De Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 636 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0131 Optimal dose of tocilizumab for the treatment of giant cell arteritis: efficacy, safety, and exposure-efficacy analysis from giacta. (15th June 2017) Authors: Stone, JH; Tuckwell, K; Dimonaco, S; Klearman, M; Mallalieu, NL; Aringer, M; Blockmans, D; Brouwer, E; Cid, MC; Dasgupta, B; Rech, J; Salvarani, C; Schett, G; Schulze-Koops, H; Spiera, R; Unizony, SH; Collinson, N Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SAT0612 The use of 18F-FDG-PET in the diagnosis of polymyalgia rheumatica (PMR) – a prospective study of 99 patients suspected of PMR. (15th June 2017) Authors: Henckaerts, L; Gheysens, O; Vanderschueren, S; Goffin, K; Blockmans, D Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1005 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗